CVE-2026-51901SuperAGI up to 0.0.14 is vulnerable to Incorrect Access Control.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
EPSS puts the chance of exploitation in the next 30 days at 0.25%, higher than 16% of scored CVEs.
SuperAGI up to 0.0.14 is vulnerable to Incorrect Access Control. The agent execution controller endpoint /api/agentexecutions/schedule allows authenticated users from one organization to schedule existing agents belonging to a different organization without proper authorization checks. The endpoint accepts an agent_id parameter but does not verify that the agent belongs to the authenticated user's organization.
- CVSS
- 8.1 HIGH (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-284
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.25% (percentile 16)
- Assigned by
- mitre
- NVD analysis
- Deferred
- Record last updated
- Oct 5, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/TransformerOptimus/SuperAGI/issues/1557
- https://gist.github.com/Ro1ME/12fc58befd7fa2693bac98a91a4debf9
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.